Stay updated on Cancer Screening with Female Biomarkers Clinical Trial
Sign up to get notified when there's something new on the Cancer Screening with Female Biomarkers Clinical Trial page.

Latest updates to the Cancer Screening with Female Biomarkers Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.3.3 to v3.3.4 appears in the page footer, and the main study details, eligibility criteria, and contacts remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page adds study locations in Texas and updates the revision to v3.3.3. It also removes the previous Texas Locations section and the HHS Vulnerability Disclosure link (v3.3.2).SummaryDifference0.3%

- Check51 days agoChange DetectedThe revision history now shows v3.3.2 added and v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedThe government funding/operating-status notice that previously warned of potential updates and updates to government operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check73 days agoChange DetectedPage changes appear to be formatting and layout adjustments only, and core study information such as eligibility criteria, locations, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check101 days agoChange DetectedCore content updated to include government operating status notice and current NIH Clinical Center status, plus a version bump to v3.2.0; the prior v3.1.0 reference was removed.SummaryDifference5%

Stay in the know with updates to Cancer Screening with Female Biomarkers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cancer Screening with Female Biomarkers Clinical Trial page.